Interferon alfa-2a
- Generic Name
- Interferon alfa-2a
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 76543-88-9
- Unique Ingredient Identifier
- 47RRR83SK7
- Background
Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.
- Indication
For the treatment of chronic hepatitis C, hairy cell leukemia, AIDS-related Kaposi's sarcoma, and chronic myelogenous leukemia. Also for the treatment of oral warts arising from HIV infection.
- Associated Conditions
- Chronic Hepatitis B Infection, Chronic Hepatitis C Virus (HCV) Infection, Chronic Myelogenous Leukemia (CML), Cutaneous T-Cell Lymphoma (CTCL), Hairy Cell Leukemia (HCL), Kaposi's Sarcoma, Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL), Thrombocytosis
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath